Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

What Happened in the Stock Market Today
What Happened in the Stock Market Today
Stocks finished the week on a positive note Friday, with the Dow Jones Industrial Average (DJINDICES: ^DJI) and the S&P 500 (SNPINDEX: ^GSPC) in positive territory throughout the session and....
Cantel Medical Corp. Keeps Pace on Its Goal
Cantel Medical Corp. Keeps Pace on Its Goal
Cantel Medical (NYSE: CMD) reported results for the first quarter, posting double-digit revenue and earnings growth to start its fiscal year. It's hard to ask for more from the medical-supply....
What's Behind Valeant Pharmaceuticals Inc.'s 11% Move Higher?
What's Behind Valeant Pharmaceuticals Inc.'s 11% Move Higher?
Shares of Valeant Pharmaceuticals (NYSE: VRX), the embattled drugmaker that's predominantly grown through acquisitions and drug-price increases over the years, surged as much as 11% by 3 p.m. EST....
Here's Why Radius Health Is Rising Today
Here's Why Radius Health Is Rising Today
After presenting data from a phase 1 study at a medical conference, shares of Radius Health (NASDAQ: RDUS), a commercial-stage biotech focused on osteoporosis and cancer, rose 15% as of 11:15 a.m.....
Cantel Medical (CMD) Q1 2018 Earnings Conference Call Transcript
Cantel Medical (CMD) Q1 2018 Earnings Conference Call Transcript
Image source: The Motley Fool.Cantel Medical (NYSE: CMD) Q1 2018 Earnings Conference CallDec. 7, 2017 11:00 a.m. ETOperatorContinue readingSource: Fool.com
Tax Reform Takes a Bite Out of Biotech Stocks
Tax Reform Takes a Bite Out of Biotech Stocks
Healthcare companies will largely benefit from tax reform that lowers the statutory business tax rate to 20% from 35%, but those in research-intensive sectors such as biotechnology could end up....
A Game-Changing Breakthrough Could Be Coming for Hemophilia Patients
A Game-Changing Breakthrough Could Be Coming for Hemophilia Patients
Patients diagnosed with hemophilia B suffer a lifetime of treatment, but that could change based on recently reported data from an early stage trial Pfizer (NYSE: PFE) and Spark Therapeutics....
Immunomedics' Data Is Good News for Seattle Genetics, Too
Immunomedics' Data Is Good News for Seattle Genetics, Too
Seattle Genetics' (NASDAQ: SGEN) deal to license Immunomedics' (NASDAQ: IMMU) sacituzumab govitecan, a breast cancer drug, was shelved earlier this year when activist investor venBio Select....
Why Sage Therapeutics Gained 70% Today
Why Sage Therapeutics Gained 70% Today
Shares of Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biotech, took flight today, after the company announced positive mid-stage trial results for its moderate-to-severe major depressive....
What Happened in the Stock Market Today
What Happened in the Stock Market Today
Stocks moved higher on Thursday, with the Dow Jones Industrial Average (DJINDICES: ^DJI) and the S&P 500 (SNPINDEX: ^GSPC) both up a little more than a quarter percentage point.Data source:....
Here's Why Marinus Pharmaceuticals Rose as Much as 41.1% Thursday
Here's Why Marinus Pharmaceuticals Rose as Much as 41.1% Thursday
Shares of clinical-stage biopharma Marinus Pharmaceuticals (NASDAQ: MRNS) rose over 41% today after larger peer Sage Therapeutics (NASDAQ: SAGE) reported positive top-line results for one of its....
It's Business as Usual at Veeva Systems Inc., and That's Good News for Shareholders
It's Business as Usual at Veeva Systems Inc., and That's Good News for Shareholders
Veeva Systems (NYSE: VEEV) has quickly become a standard-bearer in the pharmaceutical industry. The company was born out of co-founder and CEO Peter Gassner's experience while an executive at....
Why Entellus Medical Inc. Skyrocketed Higher Today
Why Entellus Medical Inc. Skyrocketed Higher Today
Entellus Medical (NASDAQ: ENTL) is up 50% at 12:33 p.m. EST after announcing that it's being acquired by Stryker (NYSE: SYK) for $24 per share.Stryker's investors seem to think the deal is just....
Allergan Stock Downgraded: What You Need to Know
Allergan Stock Downgraded: What You Need to Know
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one....
Is Exelixis, Inc. a Buy?
Is Exelixis, Inc. a Buy?
Yes.I know I'm breaking all the rules about building up suspense, etc. But I think Exelixis (NASDAQ: EXEL) is a buy right now. I think the stock will go higher over the next few years. Don't just....
Is Exact Sciences Corporation (EXAS) a Buy?
Is Exact Sciences Corporation (EXAS) a Buy?
Some investors look at a stock that has nearly quadrupled in price within less than 12 months and are excited about buying it. Others look at the same stock and are afraid that the momentum could....
Here's What Caused Sarepta Therapeutics to Shoot 13% Higher In November
Here's What Caused Sarepta Therapeutics to Shoot 13% Higher In November
A month full of news related to the progress it's making toward helping patients with Duchenne muscular dystrophy (DMD) sparked a 12.9% rally in Sarepta Therapeutics (NASDAQ: SRPT) shares last....
Here's What Caused This Marijuana Stock to Skyrocket 15% in November
Here's What Caused This Marijuana Stock to Skyrocket 15% in November
Medical marijuana has been used to treat epilepsy in patients for years, but so far, it's efficacy and safety hasn't been supported by a regulatory green light from the Food and Drug....
These 3 Healthcare Stock Dividends Could Soar If Trump Signs a Tax Reform Bill
These 3 Healthcare Stock Dividends Could Soar If Trump Signs a Tax Reform Bill
Now that tax reform bills featuring 20% tax rates have passed the House and Senate, it looks like companies across the country will get to distribute a lot more of the profits they generate. Of....
Here's Why bluebird bio's Shares Soared 24% in November
Here's Why bluebird bio's Shares Soared 24% in November
After bluebird bio (NASDAQ: BLUE) updated investors on the presentations it will be making at a key industry conference soon, its shares jumped 24.2% in November, according to S&P Global....
Why 2017 Was a Year to Forget for Merck & Co. Inc.
Why 2017 Was a Year to Forget for Merck & Co. Inc.
Better luck next year. That's what Merck & Co. (NYSE: MRK) is hoping for after a disappointing 2017. Merck stock is down year to date by 7%, while the S&P 500 index is up close to 18%.Will....
2 Top Consumer Staples Stocks to Consider Buying Now -- and 1 to Avoid
2 Top Consumer Staples Stocks to Consider Buying Now -- and 1 to Avoid
Recessions are common enough that you can count on several of them impacting your portfolio over the course of even a 10-year time horizon. That's just one reason why consumer staples stocks --....
Why Immunomedics, Inc. Is Soaring Today
Why Immunomedics, Inc. Is Soaring Today
After Immunomedics (NASDAQ: IMMU) shared some positive clinical data with investors, shares of the clinical-stage biotech focused on cancer rose 17% as of 3:10 p.m. EST on Wednesday.Immunomedics....
Why Madrigal Pharmaceuticals Stock Is On Fire Today
Why Madrigal Pharmaceuticals Stock Is On Fire Today
Shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) are rocketing higher today after the company announced positive mid-stage results for its experimental non-alcoholic steatohepatitis (NASH)....

	 
BASTIDE : Descriptif du programme de rachat d'actions (AG 30.11.2017)
BASTIDE : Descriptif du programme de rachat d'actions (AG 30.11.2017)
BASTIDE Société anonyme au capital de 3.303.261 euros Siège social : 12, avenue de la Dame, Zone euro 2000 30132 Caissargues 305 635 039 RCS NIMES Descriptif du programme de rachat d'actions....